drugset / Trial / NCT04156035

Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine

NCT04156035

RandomizedParallel-groupDouble-blindBasic science

Summary

This study is firstly designed to investigate acute and delayed effects of a single dose of ketamine on functional brain changes during emotional and cognitive challenges and at rest. Secondly, it aims to investigate whether functional brain changes after ketamine require increased glutamatergic signaling and will accordingly be modulated after pretreatment with lamotrigine.

Timeline

Start
2020-03-10
Primary completion
2020-12-10
Completion
2020-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.31 mg/kg Intravenous
Subject Lamotrigine Small molecule 300 mg Oral

Indications

No indication recorded.